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Simple Summary: The tumor microenvironment is characterized by increased tissue stiffness, low
(acidic) pH, and elevated temperature, all of which contribute to the development of cancer. Improv-
ing our in vitro models of cancer, therefore, requires the development of cell culture platforms that
can mimic these microenvironmental properties. Here, we study a new biomaterial composed of
short amino acid chains that self-assemble into a fibrous hydrogel network. This material enables
simultaneous and independent tuning of substrate rigidity, extracellular pH, and temperature, al-
lowing us to mimic both healthy tissues and the tumor microenvironment. We used this platform to
study the effect of these conditions on pancreatic cancer cells and found that high substrate rigidity
and low pH promote proliferation and survival of cancer cells and activate important signaling
pathways associated with cancer progression.
Abstract: The tumor microenvironment plays a critical role in modulating cancer cell migration,
metabolism, and malignancy, thus, highlighting the need to develop in vitro culture systems that
can recapitulate its abnormal properties. While a variety of stiffness-tunable biomaterials, reviewed
here, have been developed to mimic the rigidity of the tumor extracellular matrix, culture systems
that can recapitulate the broader extracellular context of the tumor microenvironment (including pH
and temperature) remain comparably unexplored, partially due to the difficulty in independently
tuning these parameters. Here, we investigate a self-assembled polypeptide network hydrogel as a
cell culture platform and demonstrate that the culture parameters, including the substrate stiffness,
extracellular pH and temperature, can be independently controlled. We then use this biomaterial as a
cell culture substrate to assess the effect of stiffness, pH and temperature on Suit2 cells, a pancreatic
cancer cell line, and demonstrate that these microenvironmental factors can regulate two critical
transcription factors in cancer: yes-associated protein 1 (YAP) and hypoxia inducible factor (HIF-1A).
Keywords: tumor acidosis; pH; tumor microenvironment; self-assembling polypeptides; cell culture
1. Introduction
The tumor microenvironment (TME) is a complex milieu of cancer-associated cells
and molecules, whose chemical and biophysical properties modulate cancer cell behavior,
promote cancer progression, and facilitate metastasis. The critical role of the tumor mi-
croenvironment in cancer has prompted the development of new research platforms that
can mimic its microenvironmental properties. These new platforms include more advanced
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2D cultures that recapitulate the mechanical properties of the tumor extracellular matrix
(ECM) [1], co-culture models that incorporate cancer associated fibroblasts (CAFs) [2,3]
or immune cells [4], constructs that mimic the three-dimensional architecture of tumors
(organotypic and bioprinting) [5,6], tumor organoids and spheroids [7,8] and microfluidic
approaches (tumor-on-a-chip) [9,10]. The use of these novel technologies has revealed fun-
damental insights into the role of the tumor microenvironment as a driver of cancer, thus,
highlighting the need to understand and recapitulate the complex extracellular context
of tumors.
Two key microenvironmental hallmarks characterize the tumor microenvironment:
the increased stiffness of the aberrant ECM (tumor desmoplasia) and the low extracellular
pH of the interstitial fluid (tumor acidosis). CAFs, activated by their crosstalk with cancer
cells, remodel the native ECM through the deposition of ECM fibers, the secretion of matrix
metalloproteinases (MMPs) and physically through their contractility [11,12]. This matrix
remodeling results in a high substrate stiffness, which, in turn, supports the activation
of CAFs, guides the migration of cancer cells and promotes epithelial-to-mesenchymal
transition (EMT) [13–15]. Conversely, tumor acidosis is the result of the metabolic repro-
gramming of cancer cells from oxidative phosphorylation to glycolytic metabolism, which
generates lactic acid as a byproduct [16,17].
To maintain a stable intracellular pH, cells extrude the excess protons generated in this
process through a variety of proton pumps and voltage-gated proton channels [18], which,
in turn, accumulate protons in the interstitial fluid, thus, resulting in an acidic microen-
vironment. Tumor acidosis promotes cancer cell migration, metastasis and immune cell
infiltration and contributes to the inhibition of immune surveillance and the development
of chemoresistance [19,20]. Interestingly, this switch toward glycolysis occurs even in high
oxygen availability (normoxia), a phenomenon known as the Warburg effect [20].
Significant research has focused on the development of biomaterials that can serve as
cell culture substrates with tunable stiffness (Table 1) [1]. Natural (collagen and alginate),
synthetic (polyacrylamide and polyethylene glycol) and hybrid (methacrylated hyaluronic
acid) hydrogels have been used as 2D or 3D substrates [21] to investigate stiffness-driven
phenotypic changes [22], invasion [23] and chemoresistance [24,25] in cancer cells. How-
ever, the simultaneous mimicking of both microenvironmental factors remains unexplored.
Understanding how the two factors contribute to modulating cancer cell behavior, as well
as the interplay between them, requires the use of culture platforms that allow for the
independent tuning of both the pH and substrate stiffness.
Table 1. Summary of biomaterials for mechanobiology substrates.
Material Stiffness Range Advantages Disadvantages References
Collagen 10–100 Pa~1 kPa *
Mimics the physiological ECM
Suitable for 3D fibrous matrices
Low stiffness range
Stiffness and ligands cannot be
controlled independently
[26–30]
Alginate 0.2–550 kPa Excellent bioprinting propertiesIonic and/or covalent crosslinking
Stiffness difficult to tune
independently [31–33]
Hyaluronic Acid 2–100 kPa




Requires chemical expertise [34]
PEG 2–1000 kPa **10–400 kPa High degree of design flexibility
Requires expertise to synthesize
and functionalize [35,36]
PAA 1–1000 kPa
Easy to tune over a large range of rigidity.
Independent control of stiffness and
ligand presentation
Not suitable for 3D culture [37]
PDMS 5–2000 kPa Easy to tune over a large range of rigidity.Chemically inert
Difficult to functionalize for long
term culture
Not suitable for 3D culture
[38–40]





* Rigidities in the range of 1 kPa and higher can be obtained through additional chemical crosslinking. High stiffness sponges (100 kPa) can
be achieved by freeze drying [44]. ** Storage Modulus [36,41–43].
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This kind of system, however, has remained elusive. Collagen gels typically require
neutral or alkaline pH for gelation [45,46] (although fibrils can form at a lower pH [47]),
and their fiber architecture and mechanical properties widely depend on pH [46,48]. Some
polymeric hydrogels used as cell culture matrices are pH-sensitive alone or in composites,
including chitosan and polyacrylic acid [49–51], while polyacrylamide (PAA), the standard
substrate for mechanobiology studies, is ill-suited for 3D cultures due to the cytotoxicity of
its components [21].
Here, we evaluate a new biomaterial based on a tunable self-assembled polypeptide
network (PeptiGel) and demonstrate that its mechanical properties remain stable over a
range of pH values (6.0–7.4) and temperatures (37–40◦C), thereby, enabling independent
tuning of pH, temperature and stiffness. We then assess these matrices as cell culture
platforms to recapitulate the tumor microenvironment and demonstrate that both substrate
stiffness and extracellular pH positively regulate the proliferation and survival of pancreatic
cancer cells, while temperature increases apoptosis. Finally, we demonstrate that pH and
stiffness modulate the expression of two master regulators in cancer, yes-associated protein




Collagen is one of the most abundant and ubiquitous fibrous proteins in the human
body and one of the main components of the extracellular matrix (ECM). There are 29 differ-
ent collagen types that have been identified, of which collagen type I is the most abundant
and frequently used biomaterial. Collagen fibers present a hierarchical fibrillar structure
over several scales [52] that can self-assemble into hydrogels through physical crosslink-
ing. The hydrogel architecture and fibril self-assembly depends on multiple fabrication
parameters, such as temperature and pH [48], notably requiring a neutral or alkaline pH
to form stable hydrogels [45,46]. Collagen is among the most used biomaterials owing
to its physiological nature and ability to mimic the native ECM. It excels in 3D culture
applications to observe matrix remodeling, degradation or cell migration.
The mechanical properties of collagen gels can be controlled with the tuning fabri-
cation parameters, primarily the collagen concentration, although the range of stiffness
that can be achieved without additional chemical crosslinking is limited (<1 kPa) [26,27].
Temperature and pH also affect fibril self-assembly, which ultimately impacts the gel
architecture, porosity and, thus, mechanical properties [48].
Different methods of crosslinking have been explored to improve the mechanical
properties of collagen hydrogels in order to mimic tissues of higher stiffness, including
chemical crosslinkers, such as glutaraldehyde [53], carbodiimides [28,29,54] or genipin [55],
as well as physical crosslinkers in the form of UV light or dehydrothermal treatment
(DHT) [44,52]. Composites of collagen with other materials can also be used to combine
its biological properties with the mechanical robustness of synthetic materials [54–56].
However, as a natural material, collagen suffers from batch-to-batch variability, limiting
the standardization and reproducibility of mechanical properties [21].
Due to its physiological nature, collagen natively presents cell adhesion motifs, and
cells readily attach via integrins and spread on collagen substrates without requiring
additional functionalization [57]. While this biological functionality can be highly desirable
in many applications, such as tissue engineering, it can be detrimental in mechanobiology
studies, since the ligand presentation and density cannot be decoupled from the mechanical
properties. Collagen hydrogels also undergo significant matrix contraction and can be
remodeled by encapsulated cells [58,59], resulting in changes to the architecture and
mechanical properties.
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2.2. Alginate
Alginates are a family of natural polysaccharides composed of β-d-mannuronic acid
(M) and α-l-guluronic acid (G) arranged in the form of block co-polymer subunits [60].
Alginate is derived from brown algae, offering different formulations with a wide range of
molecular weights and excellent biocompatibility. The formation of hydrogel networks is
achieved via ionic crosslinking with multivalent cations, typically Ca2+, although covalent
crosslinking is also possible [61]. RGD peptides or other cell adhesion ligands are usually
added to alginate to improve cell adhesion [62].
The mechanical properties of alginate hydrogels can be tuned through a variety of
parameters, including the concentration and molecular weight (MW) of alginate. Increasing
the concentration or the molecular weight of the polymer results in hydrogels with higher
stiffness due to an increase in polymer chain entanglement and long-range interactions
between polymer chains [31,61]. However, high MW results in high viscosity formulations
that are difficult to work with, especially in bioprinting applications. Formulations that rely
on a combination of high and low MW alginate are preferred, as they offer low viscosity
while retaining good mechanical properties [60,63].
The choice of crosslinker and the ratio of alginate to crosslinker are also key parameters
to control the hydrogel stiffness. While calcium chloride (CaCl2) is the most common choice
of ionic crosslinker, calcium sulphate (CaSO4) and calcium carbonate (CaCO3) have also
been used, resulting in hydrogels with different mechanical properties due to changes in
the gelation rate [64]. Generally, slower gelation results in more uniform gels with higher
mechanical strength and rigidity [31,64].
The choice of medium (e.g., PBS vs. DMEM) can likewise affect the mechanical
properties of alginate due to differences in the solubility of ionic crosslinkers in different
media [61,64], which impact the gelation time. Similarly, increasing the crosslinker to algi-
nate ratio increases the Young’s modulus of the resulting hydrogel due to an increase in the
crosslinking density [31,64]. The potential for covalent crosslinking through poly(ethylene
glycol) diamines [65], adipic acid dihydrazide [66] and 2-aminoethyl methacrylate [67]
offers another dimension to regulate the mechanical properties of alginate gels, either alone
or in combination with ionic crosslinking.
Alginate gels have been used as 2D substrates to study the effect of rigidity and adhe-
sion ligands on the morphology and cell/substrate interaction in chondrocytes [62] and to
study the effect of stress relaxation on cell behavior [68]. However, much mechanobiology
research with alginate gels has focused on 3D due to its excellent suitability for bioprinting.
Three-dimensional alginate matrices of different rigidity have been used to investigate the
effect of substrate stiffness on the differentiation of mesenchymal stem cells (MSCs) in 3D,
and to direct their differentiation in 3D tissue constructs [64,69]. The main disadvantage
of alginate hydrogels is the variability of their stiffness, which depends on a vast array
of fabrication and formulation parameters, making it difficult to develop standardized
hydrogels with reproducible mechanical and physical properties.
2.3. Hyaluronic Acid
Hyaluronic acid (HA) is a linear non-sulfated glycosaminoglycan (polysaccharide)
found in most tissues throughout the human body. HA is a fundamental component of the
native ECM with key roles in morphogenesis, homeostasis and wound healing; it mediates
matrix hydration and organization and provides both biochemical and biomechanical cues
to cells. Its native role in tissues makes it an excellent bioactive material for cell culture and
tissue engineering, where its biological signaling can be leveraged to direct cell behavior.
For these reasons, HA is a popular material for research and has been used for several
decades in mechanobiology, cell culture, tissue engineering, regenerative medicine and
drug delivery.
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HA presents several functional groups (carboxyl, hydroxyl and -NHCOCH3) in its
backbone, which can be targeted to produce HA derivatives with multiple functional
groups of interest [70]. The different functional modifications, in turn, offer a variety
of crosslinking methods, which have been reviewed elsewhere [71]. Thiol-modified HA
(HA-SH) can form a self-crosslinked hydrogel or be crosslinked via Michael-type addition
with several linkers, including PEG-diacrylate (PEGDA) [72] and PEG- vinylsulfone (PG-
VS) [73].
Similarly, methacrylated HA (MeHA) can be crosslinked via Michael-type addition
with dithiothreitol (DTT) or other thiolated compounds, which allows for the tuning of
mechanical properties by adjusting the proportion of DTT [74]. MeHA is also susceptible
to photocrosslinking, where the final hydrogel stiffness (2–100 kPa) can be controlled by
the MW, concentration and degree of methacrylation of the macromer [34]. More recently,
photocrosslinking between HA-SH and MeHa via thiol-ene coupling has been explored for
in situ gelation [75].
To facilitate cell adhesion, HA hydrogels are often functionalized with cell-adhesive
RGD motifs, which can be readily conjugated with MeHA through Michael addition due
to the presence of thiols in RGD peptides [34,74,76–78]. Interestingly, unmodified HA does
not contain integrin binding sites, and cells do not form focal adhesions on HA substrates.
However, cells can attach to and interact with HA hydrogels through a wide array of cell
surface receptors and HA-binding proteins (HABPs or hyaladherins), including CD44,
aggrecan and the receptor for hyaluronan mediated motility (RHAMM) [79]. However,
this can result in confounding biological interactions between cells and the HA substrate.
HA hydrogels can be synthesized with a range of rigidities similar to synthetic bio-
materials (1–100 kPa) either by tuning the concentration of crosslinker (e.g., MeHA with
DTT [76,78]) or the concentration of macromer (MeHA photopolymerization [77]). This
range of rigidities can mimic the native stiffness of different tissues and pathologies, mak-
ing HA substrates suitable for mechanobiology studies. One other interesting application
for HA is the development of dynamic hydrogels by combining different crosslinking
methods—that is, substrates that can change their mechanical properties over time or
following a user-defined trigger. This multi-step crosslinking enables spatial stiffness
patterning and temporal control over the hydrogel mechanical properties [78,80]. Softening
hydrogels have also been developed using hydrolysis-sensitive crosslinkers [74].
2.4. Polyethylene Glycol
Polyethylene glycol (PEG) is a synthetic polymer that has been widely used as a
biomaterial in cell culture, tissue engineering and mechanobiology applications. PEG
can be modified with a variety of functional groups, including carboxyl, amine, thiol
and acrylate, and is available in both linear and branched formats [81]. Interestingly,
PEG hydrogels are highly biocompatible, chemically inert and hydrophilic, making them
resistant to protein adsorption and cell adhesion [21]. While this means that PEG hydrogels
require functionalization, the low background adhesion and flexible chemistry enable
control over the ligand density and presentation [81] and create interesting patterning
opportunities through the use of microcontact printing [82] and other photolithography
techniques [83,84]. As a result, PEG hydrogels offer a very high degree of control and
flexibility compared to other synthetic biomaterials.
Owing to the chemical versatility, PEG hydrogel networks can be assembled through
a variety of crosslinking methods, including Michael-type addition [85], thiol-ene cou-
pling [86,87] and acrylate photo-polymerization [35,88], depending on the functional
groups of the modified PEG. Photopolymerization of the acrylate derivatives of PEG, such
as polyethylene glycol acrylate (PEGDA) or polyethylene glycol methacrylate (PEGMA),
are among the most common methods for PEG hydrogel fabrication and excel for 3D pho-
toencapsulation. The mechanical properties of PEG hydrogels can be tuned by adjusting
the crosslinking density, which can, in turn, be controlled by the type of crosslinker, the
crosslinker concentration and the exposure time or dose.
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The use of photopolymerization also forms the basis for dynamic hydrogels, whose
mechanical properties can be dynamically controlled through exposure to light. Both
softening [89] and stiffening [90,91] hydrogels have been achieved using photodegradable
or photo-crosslinked PEG, respectively, as well as switchable (reversible) hydrogels that
rely on azobenzene crosslinking [92]. These dynamic hydrogels have been used in the field
of mechanobiology to study mechanical memory [1].
The versatility of chemistry amenable to PEG can also be leveraged to functionalize
hydrogels with a variety of motifs and proteins of interest. Cell-adhesive ligands, such
as RGD or KQAGDV, and ECM-bound growth factors, such as TGF-β or EGF, can be
conjugated with PEGDA through acrylate copolymerization or with PEG-VS (PEG Vinyl
sulfone) via Michael-type addition. Copolymerization with diacrylate peptide derivatives
enables the use of peptide-based crosslinkers that are susceptible to proteolytic degradation
by MMPs and other cell-secreted enzymes [81].
PEG is also commonly used in combination with other biomaterials. For instance,
PEG block co-polymer gels incorporating degradable polymers, such as PLA, are used
in applications where biodegradability is desirable [81,93,94]. Modified PEG can also be
used as a crosslinker for other biomaterials, such as HA due to its chemical flexibility and
biocompatibility [72,95]. Due to the low protein adsorption and hydrophilicity, PEG has
also been used as an antifouling coat or as a background material to prevent cell adhesion
in micropatterning [96–98].
2.5. Polyacrylamide
Polyacrylamide (PAA) hydrogels are synthesized through the polymerization of acry-
lamide monomers in combination with a crosslinker (bisacrylamide). The stiffness of PAA
hydrogels can be easily tuned over a wide range (1–1000 kPa) by adjusting the proportion of
bisacrylamide (crosslinker) to acrylamide (monomer) [37]. The protocols to fabricate PAA
gels of different rigidities are well established and easily accessible, which has facilitated
the adoption of this biomaterial as a gold standard for mechanobiology studies. Moreover,
by tuning hydrogel rigidity without affecting the hydrogel density or composition, the
effect of substrate stiffness on cell behavior can be assessed independently from other
chemical or physical properties.
Similar to other synthetic hydrogels, PAA on its own does not enable cell attach-
ment, and surface functionalization with cell adhesion ligands or proteins is required.
Cell-adhesion ligands are usually covalently bound to the PAA surface using the linker
sulfo-SANPAH, although other linkers have been explored, such as N-hydroxysuccinimide-
acrylamide (NHS-AA) ester [99], hydrazine modifications [100] and 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide [101]. Interestingly, this method of functionaliza-
tion enables independent control of the ligand presentation and mechanical properties, and
thus the effect of these two factors on cell behavior can be decoupled. A variety of ECM
proteins have been used to functionalize PAA hydrogels, including collagen I, collagen IV,
fibronectin and laminin [102–105].
PAA hydrogels of different stiffness have been instrumental in the development of
mechanobiology. Stiffness-tunable PAA hydrogels have been used as 2D substrates to
demonstrate the effect of stiffness on stem cell fate [106], cancer associated fibroblast
activation [13], cancer cell malignancy [14] and cell migration [107,108].
2.6. Polydimethylsiloxane
Polydimethylsiloxane (PDMS) is another widely used synthetic polymer that produces
gels with well-defined and reproducible mechanical properties. PDMS is commercially
available as a two-part formulation of prepolymer + crosslinker, and the stiffness of the
resulting gel can be readily tuned by adjusting the proportions of the two components,
resulting in a wide range of rigidities (5 kPa to 1 MPa) [38–40]. In addition to the ease of
tuning, PDMS is highly biocompatible, hydrophobic, and chemically inert, making it ideal
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as a cell culture platform. PDMS is also widely used in microfluidics and as a biomaterial
in implants.
Due to its surface properties, PDMS needs to be functionalized to enable cell adhesion,
although cell culture on bare PDMS has been studied in certain instances [109,110]. ECM
proteins, including collagen, fibronectin and laminin, can be readily deposited on the
surface of PDMS by adsorption [39,111–114]. However, this method is not stable for long
term cell cultures [111].
Oxygen plasma treatment can be used to introduce hydroxyl groups, rendering the
surface of PDMS hydrophilic and more suitable for cell culture either directly or by fa-
cilitating the deposition of ECM proteins [111], although PDMS tends to revert to its
hydrophobic state. Long term protein conjugation can be achieved by functionalizing
the surface of PDMS with (3-aminopropyl)triethoxysilane (APTES) after oxygen plasma
treatment—a common silanization procedure to change the surface chemistry of PDMS.
ECM proteins can then be deposited on the APTES functionalized PDMS (improving
retention [115]) or covalently bound to the amine groups in APTES using glutaraldehyde
as crosslinker [116,117].
2.7. Polypeptides
Polypeptide hydrogels are composed of short, well-defined oligopeptides made up of
specific amino acid sequences that are designed to assemble into supramolecular structures.
The short peptides self-assemble into secondary structures, such as β-sheets or α-helices,
become elongated to form fibrillar structures, and when above a critical concentration these
interact with each other to form a fibrous hydrogel network with highly reproducible fiber
dimensions and pore size [118].
This design makes peptide hydrogels easy to tune and modify, as discrete changes in
the amino acid sequence can yield hydrogels with a wide range of properties [41,119,120].
The control over the sequence also provides more degrees of freedom in the hydrogel
design, thus, enabling the independent tuning of different parameters, including the
mechanical and chemical properties, cell–matrix interactions and degradability. This
flexibility in both design and tuning provides a powerful toolkit with applications beyond
mechanobiology [21].
One other major advantage of peptide hydrogels gels is the potential for direct func-
tionalization, that is, the incorporation of functional motifs directly in the hydrogel formu-
lation. By relying on amino acids, peptide gels can directly integrate proteins of interest
within their sequence without disrupting the self-assembly [121–123]. The protein of inter-
est is, thus, synthesized or expressed along with, and directly integrated into, the hydrogel
structure, eliminating the need for post-fabrication modifications and allowing for direct
control over the distribution and presentation of functional motifs. Functional motifs of
interests include RGD sequences and other cell-adhesive ECM proteins (e.g., fibronectin) or
bioactive factors (e.g., TGF-β and BMP). The high degree of control over the structure and
properties, as well as the potential for functionalization, make peptide gels very attractive
for mechanobiology studies [21].
3. Results
3.1. Self-Assembling Polypeptide Matrices Remain Mechanically Stable at Acidic pH
To serve as a platform to model the tumor microenvironment, a substrate should
enable independent tuning of both its stiffness and extracellular pH. One of the most
widely used substrates in mechanobiology is polyacrylamide (PAA) gels [37], which became
the substrate of choice in several foundational studies in the field. The stiffness of PAA
hydrogels can be controlled within a large range (1–1000 kPa) by tuning the relative
concentrations of acrylamide (monomer) and bisacrylamide (crosslinker), thereby, resulting
in gels that can be tailored to a variety of applications.
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PeptiGels are a new family of self-assembled polypeptide hydrogels that offer tunable
mechanical properties within a range similar to PAA combined with high reproducibility
and biocompatibility, making them a good candidate to recapitulate the properties of
the tumor microenvironment in 2D and 3D culture. They are based on β-sheet-forming
peptide sequences with alternating hydrophilic and hydrophobic amino acids as originally
proposed by Zhang et al. [124]. These sequences self-assemble into amphipathic β-sheets
that stack in an antiparallel manner to form fibrous supramolecular structures with fiber
diameters in the range of 3–5 nm [120].
Above a critical concentration, the fibers entangle and associate, producing a nanofi-
brous porous hydrogel that mimics the architecture of the native ECM. The viscoelastic
mechanical properties [125] and fiber network architecture (branched vs. associated) of the
hydrogel can be tuned by adjusting the amphiphilicity of the peptide, which control the
interfiber interactions, without affecting the structure of individual fibers [120,126]. The
system is designed to self-assemble in response to changes in ionic strength, such as the
addition of cell culture media, offering ease of fabrication and 3D cell encapsulation.
To assess the mechanical stability of PAA gels and PeptiGels, we decided to analyze
whether their mechanical properties were affected by changes in pH of the medium. We
observed that both soft (4 kPa) and stiff (10 kPa) PAA gels underwent significant shrinking
when subjected to pH 6.0 for 24 h, resulting in a ~20% reduction (n = 4) in the gel area
(Figure 1A,B). Conversely, different formulations of PeptiGels (Gamma 2 and Alpha 2,
corresponding to soft and stiff matrices, respectively) underwent no significant shrinking
or change in surface area when subjected to pH 6.0 (n = 4).
To further analyze the effect of pH on the mechanical stability of PAA gels and
PeptiGels, we characterized their elastic moduli at pH 7.4 and 6.0 using oscillatory rheology
(Figure 1C). Both soft and stiff PAA gels showed an increase in their Young’s Moduli at
low pH, from 4.2 ± 0.1 to 5.3 ± 0.1 kPa for soft gels, and from 10.2 ± 0.2 to 12.6 ± 0.3 kPa
for stiff gels, respectively (mean ± SEM, n = 3); a stiffening that is consistent with the
shrinking previously observed. In contrast, PeptiGels showed no significant changes in
mechanical properties when subjected to different pH conditions. These results indicate
that PeptiGels are mechanically stable over a range of pH relevant for cancer research (pH
7.4–6.0, corresponding to physiological and tumor pH, respectively).
We then focused our attention on the effect of temperature on mechanical properties
of the peptide gels. Tumors often present a slightly elevated temperature as a result of
increased metabolism and inflammation. This increase in temperature (<41 ◦C) subjects
cancer cells to chronic mild heat stress, which can increase the activation of heat shock pro-
teins (chaperones) and contribute to tumorigenesis and cancer cell survival. We subjected
PeptiGels to different conditions of pH (6.0 and 7.4) and temperature (37, 38.5 and 40 ◦C)
and observed that both Gamma 2 (soft, 4 kPa) and Alpha 2 (stiff, 10 kPa) gels were stable
at different pH over a temperature range between 37 ◦C and 40 ◦C with no significant
changes to their mechanical properties in response to temperature or acidity (Figure 2).
The mechanical and chemical stability of PeptiGels allow the independent tuning of
the extracellular pH, temperature and substrate stiffness, thus, making them suitable for
recapitulating the hallmark characteristics of the tumor microenvironment. For this reason,
we decided to use these matrices as a cell culture platform to study the combined effect of
pH, temperature and stiffness on cancer cell proliferation, apoptosis and signaling.
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Figure 1. Polyacrylamide (P A) gels (but not PeptiGels) shrank and changed mechanical properties
at acidic pH. (A) Images of gels after adjusting the pH from 7.4 to 6.0. Yellow lines represent the
perimeter of gels after shrinkage with red bracket indicating reduction in gel diameter. (B) Average
change in gel area 24 h after placing samples in pH 7.4 or pH 6.0, normalized against pH 7.4 for each
gel type. (C) Average elastic modulus across 0.1–10% strain calculated as E = 2 × G’ (1 + υ) where,
υ = Poisson’s ratio of 0.48 for PAA and 0.5 for PeptiGels. Histogram bars represent the mean ± SEM,
and dots represent average value for each experimental replicate n (for (B) n = 4, for (C) n = 3,
three gels measured per replicate), and the scale bar is 20 mm. Markers denote a significant dif-
ference between groups labeled with brackets by t-test; n.s.–not significant, ** 0.001 < p < 0.01 and
**** p < 0.0001.
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elastic modulus across 0.1–10% strain calculated as E = 2 × G’ (1 + υ) where, υ = Poisson’s ratio of 
0.5. Histogram bars represent the mean ± SEM, and dots represent average value for each experi-
mental replicate n = 3. No statistically significant difference between 37 °C, pH 7.4; 37 °C, pH 6.0; 
38.5 °C, pH 7.4; 38.5 °C, pH 6.0; 40 °C, pH 7.4; and 40 °C, pH 6.0 for Alpha 2 and Gamma 2, respec-
tively, tested with ANOVA with Dunnett’s post hoc test. 
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stroma by cancer associated fibroblasts [11,127,128]. In order to understand how these 
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(soft–4 kPa or stiff–10 kPa) and under different conditions of pH, representing physiolog-
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test), thus, suggesting that a combination of acidic pH and high temperature might have 
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Figure 3. Low, tumor-mimicking pH increased the proliferation of Suit-2 007 cells cultured on soft and stiff self-assembling 
peptide hydrogels. (A,B) Widefield, epifluorescent images of Ki67 as a marker of proliferation for cells cultured on soft 
(Gamma 2) and stiff (Alpha 2) Manchester BIOGEL PeptiGels in physiologically healthy (7.4) and tumor-mimicking (6.0) 
pH at 37 °C (A) and 40 °C (B). Ki67 (green), actin (red) and nucleus (blue). Scale bar represents 50 µm. (C,D) Percentage 
of Ki67 positive nuclei presented in (A,B), respectively. Histogram bars represent the mean ± SEM, and dots represent the 
average percentage of Ki67 positive cells per individual sample, across three experimental replicates. Three experimental 
replicates. * markers denote a significant difference between bracket-marked groups by t-test, **** p < 0.0001; ‡ markers 
denote a significant difference from soft pH 7.4 condition by ANOVA with Dunnett’s post hoc test; n.s.–not significant, ‡‡ 
0.001 < p < 0.01 and ‡‡‡‡ p < 0.0001. 
3.3. Extracellular pH and Matrix Stiffness Regulate Cancer Cell Apoptosis 
Figure 3. Low, tumor-mimicking pH increas d the proliferation of Suit-2 007 cells cultured on soft and
stiff self-assembling peptide hydrogels. (A,B) Widefield, epifluorescent images of Ki67 as a marker of
proliferation for cells cultured on soft (Gamma 2) and stiff (Alpha 2) Manchester BIOGEL PeptiGels in
physiologically healthy (7.4) and tumor-mimicking (6.0) pH at 37 ◦C (A) and 40 ◦C (B). Ki67 (green),
actin (red) and nucleus (blue). Scale bar represents 50 µm. (C,D) Percentage of Ki67 positive nuclei
present d in (A,B), respectively. Histogram bars represent the mean ± SEM, and dots represent the
average percentage of Ki67 positive cells per individual sample, across three experimental replicates.
Three experimental replicates. * markers denote a significant difference between bracket-marked
groups by t-test, **** p < 0.0001; ‡ markers denote a significant difference from soft pH 7.4 condition
by ANOVA with Dunnett’s post hoc test; n.s.–not significant, ‡‡ 0.001 < p < 0.01 and ‡‡‡‡ p < 0.0001.
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3.3. Extracellular pH and Matrix Stiffness Regulate Cancer Cell Apoptosis
We then set to investigate the effect of extracellular pH and substrate stiffness on
cancer cell apoptosis. To this end, we characterized the expression of cleaved caspase 3
(Cc3+) on Suit2 cells via immunofluorescence. In both soft (Gamma 2) and stiff (Alpha 2)
PeptiGels, we observed a decrease in the relative mean fluorescence intensity of Cc3+
between pH 7.4 (1.00 ± 0.06 for soft gels, 0.77 ± 0.03 for stiff gels; mean ± SEM, n = 14 and
13 for soft and stiff, respectively) and pH 6.0 (0.50 ± 0.03 for soft gels and 0.33 ± 0.01 for
stiff gels; mean ± SEM, n = 13), indicating a decrease in the apoptosis rate with acidic pH
(Figure 4A,C).
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Figure 4. Apoptosis of Suit-2 007 cells is decreased as a result of tumor pH (6.0) and higher stiffness.
(A,B) Widefield, epifluorescent images of Cc3+ (Cleaved caspase 3) as a marker of apoptosis, for cells
cultured on soft (Gam a 2) and stiff (Alpha 2) Manchester BIOGEL PeptiGels in physiologically
healthy (7.4) and tumor-mimicking (6.0) pH at 37 ◦C (A) and 40 ◦C (B). Cc3+ (green), actin (red)
and nucleus (blue). Scale bar represents 50 µm. (C,D) MFI-mean fluorescence intensity (expressed
in arbitrary units) of Cc3+ stained cells presented in (A,B), respectively. Histogram bars represent
the mean ± SEM, and dots represent the average Cc3+ intensity within a sample (20 cells measured
per sample) across three experimental replicates. * markers denote a significant difference between
bracket-marked groups by t-test, **** p < 0.0001. ‡ markers denote a significant difference from soft
pH 7.4 condition by ANOVA with Dunnett’s post hoc test; ‡‡ 0.001 < p < 0.01, ‡‡‡ 0.0001 < p < 0.001
and ‡‡‡‡ p < 0.0001.
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Interestingly, at both pH 7.4 and 6.0, we observed that cells cultured on stiff gels
displayed a lower Cc3+ expression (i.e., a lower apoptosis rate) compared with the cells
cultured on soft gels at the same pH (p < 0.001, Mann–Whitney test), suggesting that
mechanical stimuli from the stiff substrate promoted cancer cell survival and that both
extracellular pH and substrate rigidity contributed to the regulation of cancer cell apoptosis.
We then conducted the same experiments at 40 ◦C to analyze the effect of mild heat
stress on cancer cell apoptosis as well as its interaction with pH and stiffness (Figure 4B,D).
In all the conditions analyzed here, we observed an increase in Cc3+ expression at 40 ◦C
relative to the same conditions of pH and stiffness at 37 ◦C, except for soft (Gamma 2)
gels at pH 6.0. This effect was more significant on stiff PeptiGels at pH 6.0 (the conditions
that more closely resemble the tumor microenvironment), where we observed a two-fold
increase in apoptosis between 37 and 40 ◦C (Mann–Whitney test, p < 0.0001, n = 13 and 17
for 37 and 40 ◦C, respectively).
These results are consistent with an increase in apoptosis caused by heat stress. Taken
together with the upregulation of proliferation by pH and temperature, these results
suggest that microenvironmental factors play an important role in regulating cancer cell
proliferation and survival and highlight the importance of recapitulating the wider extra-
cellular context of the tumor microenvironment.
3.4. Extracellular pH, Temperature and Matrix Stiffness Regulate YAP-1 and HIF-1A Signaling
The Yes-associated protein 1 (YAP-1) is a transcription factor that plays a fundamental
role in cellular mechanotransduction. YAP-1 is activated downstream of a variety of me-
chanical stimuli, most notably high substrate stiffness, and coordinates the cell’s mechanical
activity. While inactive, YAP-1 remains cytoplasmic; however, it translocates to the nucleus
when activated where it carries out its function as a transcription factor to regulate the
expression of a variety of genes, including connective tissue growth factor (CTGF) and
Ankyrin-1 (ANKRD1).
Using immunofluorescence, we characterized the nuclear to cytoplasmic ratio of YAP
in Suit2 cells cultured on different conditions of substrate rigidity and pH (Figure 5A,C).
The nuclear to cytoplasmic ratio increased from 0.60 ± 0.03 at pH 7.4 to 0.88 ± 0.03 at
pH 6.0 in soft substrates and from 0.73 ± 0.04 at pH 7.4 to 1.03 ± 0.04 at pH 6.0 in stiff
substrates (mean ± SEM, n = 11). Moreover, cells cultured on stiff gels displayed a higher
nuclear to cytoplasmic YAP ratio compared with those cultured on soft gels at a given pH
(p < 0.05 at pH 7.4 and p < 0.01 at pH 6.0, Mann–Whitney Test, n = 11), consistent with the
activation of YAP via mechanotransduction that has been previously observed.
The upregulation of YAP-1 downstream genes CTGF and ANKRD1 by substrate
stiffness has been reported by our group and others. Here, we analyzed the effect of pH on
the expression of CTGF and ANKRD1 at the mRNA via RT-qPCR and observed a similar
upregulation at acidic pH compared to pH 7.4 (Figure S1). These results indicate that low
pH can activate YAP independently from the substrate stiffness and suggest that both
extracellular pH and stiffness contribute to the activation of YAP and its downstream genes
in cancer.
At 40 ◦C, we observed a similar trend for the nuclear/cytoplasmic YAP ratio as
a function of substrate stiffness and pH (Figure 5B,D), with no significant differences
between each condition at 40 ◦C and the corresponding condition at 37 ◦C, except for
Suit2 cells cultured on stiff (Alpha 2) gels at pH 6.0, where we found a slight decrease
in the nuclear/cytoplasmic YAP ratio, from 1.03 ± 0.04 at 37 ◦C to 0.88 ± 0.03 at 40 ◦C
(mean ± SEM, n = 11 and 23 samples for 37 and 40 ◦C, respectively).
HIF-1A is another master regulatory switch that plays a central role in cancer pro-
gression by controlling broad signaling pathways involved in metabolism, survival and
angiogenesis. Its expression correlates with increased malignancy and poor prognosis, and
it represents an important therapeutic target. While the mechanisms of HIF-1A regulation
by hypoxia in cancer are well understood, the role of other microenvironmental factors
in modulating HIF-1A has not been characterized. Here, we analyzed the expression of
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HIF-1A by suit2 cells cultured in PeptiGels of different rigidity (soft and stiff) and pH
(7.4 and 6.0) using immunofluorescence.




Figure 5. Acidic pH (6.0) of culture media and tumor-mimicking stiffness of the substrate increase nuclear translocation 
of YAP in Suit-2 007 cells. (A-B) Widefield, epifluorescent images of YAP (Yes-associated protein) for cells cultured on soft 
(Gamma 2) and stiff (Alpha 2) Manchester BIOGEL PeptiGels in physiologically healthy (7.4) and tumor-mimicking (6.0) 
pH at 37 °C (A) and 40°C (B). Protein of interest (green), actin (red) and nucleus (blue). Scale bar represents 50 µm. (C,D) 
Nuclear/cytoplasmic signal ratio assessed by measuring the MFI-mean fluorescence intensity (expressed in arbitrary units) 
of YAP-stained cells presented in (A,B), respectively. Histogram bars represent the mean ± SEM, and dots represent the 
average yap nuclear/cytoplasm ratio within a sample (20 cells measured per sample) across three experimental replicates. 
* markers denote a significant difference between bracket-marked groups by t-test, **** p < 0.0001. ‡ markers denote a 
significant difference from soft pH 7.4 condition at 37 °C by ANOVA with Dunnett’s post hoc test; ‡ 0.01 < p < 0.05, ‡‡‡ 
0.0001 < p < 0.001 and ‡‡‡‡ p < 0.0001. 
HIF-1A is another master regulatory switch that plays a central role in cancer pro-
gression by controlling broad signaling pathways involved in metabolism, survival and 
angiogenesis. Its expression correlates with increased malignancy and poor prognosis, 
Figure 5. Acidic pH (6.0) of culture edia and tumor-mimicking stiffness of the substrate i crease
nuclear translocation of YAP in Suit-2 007 cells. (A-B) Widefield, epifluorescent images of YAP
(Yes-associated protein) for cells cultured on soft (Gamma 2) and stiff (Alpha 2) Manchester BIOGEL
PeptiGels in physiologically healthy (7.4) and tumor-mimicking (6.0) pH at 37 ◦C (A) and 40◦C (B).
Protein of interest (green), actin (red) and nucleus (blue). Scale bar represents 50 µm. (C,D) Nu-
clear/cytoplasmic signal ratio assessed by measuring the MFI-mean fluorescence intensity (expressed
in arbitrary units) of YAP-stained cells presented in (A,B), respectively. Histogram bars represent the
mean ± SEM, and dots represent the average yap nuclear/cytoplasm ratio within a sample (20 cells
measured per sample) across three experimental replicates. * markers denote a significant difference
between bracket-marked groups by t-test, **** p < 0.0001. ‡ markers denote a sig ificant difference
from soft pH 7.4 condition at 37 ◦C by ANOVA with Dunnett’s post hoc test; ‡ 0.01 < p < 0.05,
‡‡‡ 0.0001 < p < 0.001 and ‡‡‡‡ p < 0.0001.
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We observed that, in both soft and stiff gels, the HIF-1A expression increased at low
pH (Figure 6A,C), from 1.00 ± 0.03 to 1.77 ± 0.09 in soft gels and from 1.56 ± 0.07 to
2.59 ± 0.20 in stiff gels (mean ± SEM, n = 20, 20, 13 and 14 in soft 7.4, soft 6.0, stiff 7.4 and
stiff 6.0, respectively). Conversely, when we studied the expression of HIF-1A using qPCR,
we found no significant difference at the mRNA level between pH 7.4 and pH 6.0 (Figure
S2), suggesting that the regulation of HIF-1A by pH occurs at the protein level.
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Figure 6. Ac dic pH (6.0) of c ltur media and tu or-mimicking stiffness of the substrate increase the
expression of Hypoxia Inducible Factor 1 Alpha in Suit-2 007 cells. (A,B) Widefield, epifluorescent
images of HIF1A for cells cultured on soft (Gamma 2) and stiff (Alpha 2) Manchester BIOGEL
PeptiGels in physiologically healthy (7.4) and tumor-mimicking (6.0) pH at 37 ◦C (A) and 40 ◦C
(B). Pr tein of intere t (green), actin (red) and nucleus (blue). Scale b rep ese ts 20 µm. (C,D)
Protein expression measured as the MFI-mean fluorescence intensity (expressed in arbitrary units)
of HIF1A-stained cells presented in (A,B), respectively. Histogram bars represent the mean ± SEM,
and dots represent the average yap nuclear/cytoplasm ratio within a sample (20 cells measured
per sample) across three experimental replicates. * Markers denote a significant difference between
bracket-marked groups by t-test, *** 0.0001 < p< 0.001 and **** p < 0.0001. ‡ markers denote a
significant difference from soft pH 7.4 condition at 37 ◦C by ANOVA with Dunnett’s post hoc test;
n.s not significant, ‡‡ 0.001 < p < 0.01, and ‡‡‡‡ p < 0.0001.
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We then studied the effect of temperature (40 ◦C) on the expression of HIF-1A on
Suit2 cells subjected to the same conditions of pH and substrate stiffness (Figure 6B,D) and
observed a similar trend to those cultured at 37 ◦C. In both soft and stiff PeptiGels at 40 ◦C,
the cells showed a higher expression of HIF-1A at pH 6.0 (2.08 ± 0.09 and 1.62 ± 0.06 for
soft and stiff gels, respectively, mean ± SEM, n = 31 and 23 for soft and stiff respectively)
compared to pH 7.4. (0.95 ± 0.04 and 1.05 ± 0.05 for soft and stiff gels, respectively, mean
± SEM, n = 28 for both groups). However, we found that, in stiff gels (at both pH 7.4
and pH 6.0), the expression of HIF-1A decreased with the increase in temperature (40 ◦C)
with respect to the same conditions of pH and stiffness at 37 ◦C (for pH 7.4, p < 0.0001,
n = 13 and 28 for 37 and 40 ◦C, respectively; and for pH 6.0, p < 0.001, n = 14 and 23 for 37
and 40 ◦C, respectively. Mann–Whitney test). These results indicate that mild heat stress
antagonized the upregulation of HIF-1A by acidic pH and stiffness.
4. Discussion
Tunable cell culture platforms are a fundamental research tool in fields as diverse as
cell and developmental biology, mechanobiology, tissue engineering and cancer research.
The selection of the substrate biomaterial often results in a tradeoff between flexibility, ease
of tuneability and 3D scalability. Here, we assessed the suitability of a self-assembling
peptide hydrogel as a cell culture platform to recapitulate the conditions of the tumor
microenvironment: low extracellular pH, high substrate stiffness and elevated temperature.
Compared to PAA, we found that the mechanical properties of this gel were not affected by
the pH or temperature of the medium, allowing us to tune the extracellular pH, stiffness
and temperature independently while maintaining the other factors as constant.
By tuning the different culture parameters, it is possible to analyze both the inde-
pendent contribution of different factors as well as their interactions in order to develop
a broader picture of the role of the tumor microenvironment on cancer cell behavior.
Self-assembling peptide hydrogels are amenable to 3D scalability, contrary to synthetic
substrates, like PAA and PDMS, thus, facilitating translation between 2D and 3D models.
However, more work is required to understand the interaction between cells and fibrous
peptide networks.
Here, we leveraged the stability and tunability of a peptide hydrogel to explore
the response of pancreatic cancer cells to different combinations of pH, temperature and
substrate stiffness. We found that a low pH increased proliferation and reduced apoptosis,
in line with previous studies that analyzed the effect of extracellular pH on other cancer cell
lines [133–135]. Consistent with previous reports, we found that mild heat stress (40 ◦C)
increased cell apoptosis.
However, while we did not find the substrate stiffness or pH to have a protective
effect on heat stress, cells subjected to the conditions that more closely resembled the
tumor microenvironment (stiff substrate, pH 6.0, 40 ◦C) still displayed lower levels of
Cc3+ (apoptosis) compared with those under physiological conditions (soft substrate,
pH 7.4, 37 ◦C), indicating that the tumor microenvironment had a net positive effect
on cancer cell survival. These results illustrate the importance of considering multiple
microenvironmental factors when designing cancer models, as different culture parameters
can have synergistic or antagonistic effects on different aspects of cell behavior.
We found that the substrate stiffness, temperature and pH all positively regulated HIF-
1A at the protein level. We previously reported that high substrate stiffness upregulated
HIF-1A at the mRNA level [136]. Here, we found that extracellular pH had no significant
effect on HIF-1A mRNA. Under physiological conditions, HIF-1A is regulated through
its canonical oxygen-dependent pathway. HIF-1A is continuously produced; however, in
normoxia, the proteins prolyl hydroxylase (PHD) and von Hippel–Lindau (VHL) act in
tandem to ubiquitinate HIF-1A, tagging it for proteasomal degradation. In the absence
of oxygen (hypoxia), this mechanism of degradation is inhibited, resulting in rapidly
increasing HIF-1A levels. It is possible that low pH (6.0) similarly impairs the mechanism
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of HIF-1A degradation by PHD and VHL, thereby, increasing its protein levels without
affecting mRNA expression.
While HIF-1A expression in cancer has been studied in the context of its metabolism
and hypoxia, here, we found that matrix stiffness could also modulate its expression
independently from the oxygen availability. The regulation of HIF-1A by mechanical
stimuli has been previously reported in the vasculature, where HIF-1A expression was
induced in endothelial cells by low wall shear stress [137] and in cardiomyocytes by
stretching [138]. Our group also reported that HIF-1A expression was reduced by tamoxifen,
a drug known to inhibit cell contractility and mechanosensing [136].
This mechanism of mechano-regulation of HIF-1A by matrix stiffness represents
an unexplored angle to inhibit HIF-1A expression and could provide novel therapeutic
targets. By regulating HIF-1A, this mechanism could provide a link between cancer
mechanotransduction and metabolism as well as a potential pathway for mechanical cues
from the pre-malignant ECM to drive metabolic changes in epithelial cells during the
early stages of cancer evolution. However, more work will be required to identify the
mechanisms of regulation and elucidate the signaling pathway.
5. Materials and Methods
5.1. Cell, Reagents, and Antibodies
Suit2-007 cells were kindly donated by Prof. Malte Buchholz from Philipps-Universität
Marburg. Cells were maintained in Dulbecco’s Modified Eagle’s Medium-low glucose
(Cat. No. D5546, Sigma Aldrich, Dorset, UK) supplemented with 10% v/v FBS (Cat No.
F7524, Sigma Aldrich, Dorset, UK), l-glutamine (Cat No. G7513, Sigma Aldrich, Dorset,
UK), 1% v/v penicillin/streptomycin (Cat. No. P4333 Sigma Aldrich, Dorset, UK) and 1%
v/v Fungizone/amphotericin B (Cat. No. 15290-026 Gibco, Carlsbad, CA, USA). Coverslips
(Cat No. 631-0149P, cover glasses, 13 mm diameter, thickness No.1, VWR, Radnor, PA,
USA) were coated with Manchester BIOGEL.
Peptide gels (PeptiGel Gamma 2 and PeptiGel Alpha 2, Manchester BIOGEL, Alderley
Park, Cheshire, UK) were incubated in media for 1 h and coated with 10 µg/mL of
Fibronectin (Cat No. PHE0023, Gibco, Carlsbad, CA, USA) in PBS (Cat. No. D8537, Sigma
Aldrich, Dorset, UK) for 45 min at 37 ◦C. The cells were collected and counted using
a hemocytometer and seeded on the peptide gels (10,000 cells per gel). The cells were
cultured for 24 h in medium with the pH adjusted to 7.4 following a 24-h incubation with
pH 7.4 or 6.0 in 37 or 40 ◦C incubation for the final 2 h.
The primary antibodies used in the experiments were YAP (SanCat. No. sc101199,
Santa Cruz Biotechnology, Dallas, TX, USA, 1/200), Caspase-3 (Cat. No. ab13847, Abcam,
Cambridge, UK, 1/100), Ki67 (Cat. No. 14-5698-82, ThermoFisher, Carlsbad, CA, USA,
1/100) and HIF1A (Cat. No. ab2185, Abcam, Cambridge, UK, 1/100). The secondary
antibodies and dyes used in the experiments were anti-mouse IgG (H + L) Alexa-488
(Cat. No. A11029, Invitrogen, Carlsbad, CA, USA, 1/400), anti-rabbit IgG (H + L) Alexa-488
(Cat. No. A11034, Invitrogen, Carlsbad, CA, USA, 1/400), anti-rat IgG (H + L) Alexa-488
(Cat. No. A11006, Invitrogen, Carlsbad, CA, USA, 1/400) and Alexa Fluor™ 546 Phalloidin
(Cat. No. A22283, Invitrogen, Carlsbad, CA, USA, 1/400).
5.2. Gel Preparation and Gel Contraction Assay
PeptiGels (Manchester BIOGEL, Alderley Park, Cheshire, UK) were used as supplied,
and layers were prepared as described above. For the polyacrylamide gels, fabrication
coverslips were covered with 3-(trimethoxysilyl) propyl methacrylate (Cat No. 440159,
Sigma, Dorset, UK), incubated at room temperature for 5 min, washed in dH2O and left to
dry at room temperature. Polyacrylamide gels of 4 and 10 kPa were prepared according to
the protocol adapted from [139]. A working solution of PBS, acrylamide/bis-acrylamide
(29:1) 40% vol (Cat. No. A7802, Sigma, Dorset, UK), TEMED (Cat. No. T9281, Sigma) and
10% ammonium persulfate were mixed at concentrations to achieve varying gel stiffness.
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A small drop of this working solution was applied to activated coverslips, which were
placed face down on hydrophobic, dichlorodimethylsilane (Cat. No. 440272, Sigma, Dorset,
UK) treated glass microscope slides and left to polymerize at room temperature for 45 min.
Both gels were prepared to reach the coverslip edges, then coverslips were placed in a
24-well plate. After, the fabrication gels were incubated in the pH7.4 cell culture media
for 24 h, followed by 24 h incubation in pH 6.0 or pH 7.4 cell culture media. Subsequently,
the samples were imaged using brightfield with DIC. The change in area was calculated
relative to the initial area of the respective coverslips.
5.3. Rheometry
The PeptiGel samples for stiffness measurements were prepared as described above.
Polyacrylamide gels were prepared on dichlorodimethylsilane treated coverslips to im-
prove the gel detachment. The stiffness at varying temperatures and pH values was assayed
using an ar2000ex rheometer (TA Instruments, New Castle, DE, USA). Gels were loaded
onto the device and measured under a strain sweep of 0.1–10%. The elastic modulus
was calculated as E = 2 × G’ (1 + υ) where υ = Poisson’s ratio of 0.48 for PAA and 0.5
for PeptiGels.
5.4. Immunofluorescence Staining
Cell immunofluorescence staining was done on coverslips with PeptiGels coated with
10 µg/mL fibronectin in PBS (Cat. No. PHE0023, Gibco, Carlsbad, CA, USA). Following
pertinent treatment, the cells were fixed with 4% w/v paraformaldehyde (Cat. No. P6148,
Sigma, Dorset, UK) in D-PBS (Cat. No. D8537 Sigma, Dorset, UK) for 10 min, permeabilized
with 0.1% w/v saponin (×100-100ML, Sigma, Dorset, UK) and then blocked with 1% w/v
BSA (Cat. No. A8022 Sigma, Dorset, UK) and 22.52 mg/mL glycine (Cat. No. G8898, Sigma,
Dorset, UK) in PBST for 30 min. After blocking, the cells were incubated with primary
antibodies prepared in blocking solution overnight at 4 ◦C in a humidified chamber. Then,
the cells were washed in D-PBS and incubated with Alexa Fluor 488-conjugated secondary
antibodies and phalloidin prepared in PBS for 1 h at room temperature. Finally, the
coverslips were washed in PBS and mounted in mounting reagent with 4,6-diamidino-2-
phenylindole (Cat. No. P36931, Invitrogen, Carlsbad, CA, USA).
5.5. Immunofluorescence Imaging Analysis
Widefield fluorescent images were taken with a Nikon Ti-e Inverted Microscope
(Ti Eclipse, C-LHGFI HG Lamp, CFI Plan Fluor 40 × NA 0.6 air objective; Nikon Europe,
Amsterdam, Netherlands; Neo sCMOS camera; Andor, Belfast, UK) with NIS elements AR
software. The staining intensity was measured in Fiji [140] using the “mean gray value”
parameter applied to a region of interest (ROI) created for manually segmented cells based
on DIC images. Mean gray values for each image’s background were subtracted for each
measured staining intensity. Images for DAPI were obtained in order to visualize the
nucleus for the quantification of YAP staining regions.
Nuclear ROIs were defined through automated thresholding of the DAPI channel
in ImageJ. Measurements of the YAP fluorescence intensity in the nucleus were obtained
in ImageJ (measured mean grey value) using the nuclear ROI (colocalization with DAPI)
and compared against the cytoplasmic YAP staining intensity (measured mean grey value)
for the whole cell ROI with subtracted nuclear ROI. Ratios of the nuclear to cytoplasm
fluorescence intensities were calculated in order to analyze the localization of YAP in the
different cells.
5.6. qPCR
The total RNA was extracted using the RNeasy Mini kit (Cat. No. 74104, Qiagen,
Hilden, Germany), and 1 µg of total RNA was reverse-transcribed using the High-Capacity
RNA-to-cDNA kit (Cat. No. 4387406Applied Biosystems, Carlsbad, CA, USA) according to
the manufacturer’s instructions. qPCR was performed using the SYBR Green PCR Master
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Mix (Cat. No. 4309155, Applied Biosystems, Carlsbad, CA, USA) with 100 ng cDNA input
in 20 µL of reaction volume. The RPL0 (60S acidic ribosomal protein) expression level was
used for normalization as a housekeeping gene.
The primer sequences were as follows: RPLP0: forward, 5′-CGGTTTCTGATTGGCTAC-
3′, RPLP0: reverse, 5′-ACGATGTCACTTCCACG-3′; CTGF: forward, 5′-TTAAGAAGGGCA
AAAAGTGC-3′ and reverse, 5′-CATACTCCACAGAATTTAGCTC-3′; ANKDR1: forward,
5′-TGAGTATAAACGGACAGCTC-3′ and reverse, 5′-TATCACGGAATTCGATCTGG-3′;
and HIF1A: forward, 5′-AAAATCTCATCCAAGAAGCC-3′ and reverse: 5′-AATGTTCCAA
TTCCTACTGC-3′; All primers were used at a 300 nM final concentration. The relative gene
expression was analyzed by the comparative 2–∆∆Ct method.
5.7. Statistical Analysis
All statistical analyses were conducted with the Prism software (version 8, GraphPad).
Data were generated from multiple repeats of different biological experiments to obtain
the mean values and SEM displayed throughout. p values were obtained through the
Mann–Whitney test on unpaired samples with parametric tests used for data with a normal
distribution. ANOVA and the post hoc Dunnett’s test were used to perform a multiple
comparison test on normally distributed data, and the Kruskal–Wallis test was used for
the multiple comparison of non-normally distributed data. Significance was set at p < 0.05
where graphs show significance through symbols (*/‡ 0.01 < p < 0.05; **/‡‡ 0.001 < p < 0.01;
***/‡‡‡ 0.0001 < p < 0.001; and ****/‡‡‡‡ p < 0.0001).
6. Conclusions
The development of novel in vitro models of cancer requires biomaterial substrates
that can recapitulate the properties of the tumor microenvironment, including the substrate
stiffness, acidic pH, and elevated temperature. Polyacrylamide gels, the standard choice for
mechanobiology studies, do not allow for independent tuning of these culture parameters.
Here, we demonstrate that self-assembling polypeptide (PeptiGel) hydrogels are a suitable
platform to culture cancer cells under different conditions of pH, stiffness and temperature
and to analyze the effect of these microenvironmental factors on the proliferation, apoptosis
and signaling of Suit2 cells, a pancreatic cancer cell line.
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